- Home
- PANW vs ABT Comparison
PANW vs ABT Comparison
Compare PANW & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PANW | ABT |
|---|---|---|
| Founded | 2005 | 1888 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer peripheral equipment | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 234.5B | 152.9B |
| IPO Year | 2012 | 2006 |
Fundamental Metrics
Financial Performance| Metric | PANW | ABT |
|---|---|---|
| Price | $290.94 | $90.51 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 39 | 20 |
| Target Price | ★ $216.28 | $130.90 |
| AVG Volume (30 Days) | 8.3M | ★ 9.3M |
| Earning Date | 05-19-2026 | 04-16-2026 |
| Dividend Yield | N/A | ★ 2.76% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.79 | 0.61 |
| Revenue | $2,273,100,000.00 | ★ $44,328,000,000.00 |
| Revenue This Year | $24.93 | $10.75 |
| Revenue Next Year | $19.97 | $8.10 |
| P/E Ratio | $362.53 | ★ $143.90 |
| Revenue Growth | ★ 29.04 | 5.67 |
| 52 Week Low | $139.57 | $81.97 |
| 52 Week High | $302.95 | $137.49 |
Technical Indicators
Market Signals| Indicator | PANW | ABT |
|---|---|---|
| Relative Strength Index (RSI) | 67.09 | 53.78 |
| Support Level | $179.81 | $86.02 |
| Resistance Level | $302.95 | $92.73 |
| Average True Range (ATR) | 11.72 | 2.01 |
| MACD | -1.67 | 0.21 |
| Stochastic Oscillator | 86.21 | 59.90 |
Price Performance
Historical ComparisonAbout PANW Palo Alto Networks Inc.
Palo Alto Networks is a platform-based cybersecurity vendor with product offerings covering network security, cloud security, and security operations. The California-based firm has more than 80,000 enterprise customers across the world, including more than three-fourths of the Global 2000.
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.